The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

Mon, 04th Dec 2023 16:56

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

The FTSE 100 index closed down 16.39 points, 0.2%, at 7,512.96. The FTSE 250 ended down 47.40 points, 0.3%, at 18,361.25, and the AIM All-Share closed down 1.05 points, or 0.2%, at 715.24.

The Cboe UK 100 ended down 0.3% at 749.31 and the Cboe UK 250 closed down 0.3% at 15,878.49. However, the Cboe Small Companies ended up 0.4% at 13,413.09.

In European equities on Monday, the CAC 40 in Paris ended down 0.2%, while the DAX 40 in Frankfurt ended up marginally.

Investors this week will be carefully eyeing the outlook for US interest rates. The latest nonfarm payrolls report is on Friday and the precursor ADP reading on Wednesday.

Fed Chair Jerome Powell on Friday said it is still "premature" to speculate on when the US central bank will start cutting interest rates.

However, on Monday, gold prices hit an all-time high and became the subject of headlines around interest rates.

The yellow metal hit an intraday high on USD2,134 an ounce during the morning session on Monday, but then retreated amid questions around US monetary policy trajectory. Gold was quoted at USD2,025.87 an ounce at the London equities close Monday, down against USD2,055.14 at the close on Friday.

"The precious metal has been driven higher by renewed violence in the Middle East, a weaker US dollar and falling government bond yields. Investors often put money into gold where there are geopolitical tensions as it is considered to be a safe-haven asset. The weaker dollar can also make gold more affordable for non-US buyers," explained AJ Bell's Mould.

"Investors increasingly believe the US central bank will start to cut interest rates next year and that could put further pressure on the dollar."

The pound was quoted at USD1.2620 at the London equities close Monday, down compared to USD1.2659 at the close on Friday.

The euro stood at USD1.0817 at the European equities close Monday, lower against USD1.0859 at the same time on Friday. Against the yen, the greenback faded to JPY147.02 from JPY147.37.

Stocks in New York were lower at the London equities close, with the DJIA down 0.4%, the S&P 500 index down 0.9%, and the Nasdaq Composite down 1.6%.

In the FTSE 100, miners closed down at the bottom of the index.

Anglo American was the worst amongst the losers, down 3.7%. Meanwhile, Glencore, Rio Tinto and Antofagasta were down 3.1%, 2.7% and 2.6% respectively.

Oil firms Shell and BP also tracked lower on lower oil prices. They were down 1.2% and 1.4%, respectively.

Brent oil was quoted at USD78.53 a barrel at the London equities close Monday, down from USD80.73 late Friday.

Rolls-Royce closed up 3.1% at the top of the index.

Rolls-Royce has "far higher" customer advances from its long-term service agreements on its balance sheet than it had previously disclosed, according to JPMorgan.

This prompted the investment bank to upgrade its outlook for the London-based jet engine maker. Since April 2018, JPMorgan rated Rolls-Royce shares at either 'underweight' or 'neutral'. It now rates the firm at 'overweight.'

In the FTSE 250 index, 888 shot up 19%, after it rebuffed a GBP700 million takeover bid from gambling software provider Playtech.

Citing City sources, the Sunday Times said Playtech had made an indicative approach in July, pitching an offer at 156 pence per share. Bookmaker 888 believed this undervalued the firm. The Gibraltar-based betting operator, which owns the William Hill and Mr Green brands.

Playtech shares rose 1.1%.

Amongst London's small caps, Petrofac jumped 22%, despite predicting a free cash flow miss.

The provider of services to the energy industry also said it is mulling a "range of strategic and financial options" to bolster its coffers.

"Management has been making progress in organic actions to unwind working capital, collect receipts on ongoing and new contracts and to unlock long-outstanding commercial settlements. In addition, management is considering the sale of non-core assets, and is actively engaged in discussions with financial investors to take a non-controlling position in certain other components of the business portfolio," it added.

On AIM, Cornerstone FS shares rocketed 35%.

The cloud-based payment services provider predicts 2023 adjusted earnings before interest, tax, depreciation and amortisation "materially above current market expectations". For 2022, it had reported an adjusted Ebitda loss of GBP869,319 of 2022, narrowed from GBP1.3 million in 2021.

On the other hand, Fusion Antibodies lost 23%. It reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

In Tuesday's UK corporate calendar, there are half year results from Ashtead, as well as first quarter results from Ferguson.

On the economic calendar, a slew of services purchasing managers' index releases are out for China, the EU, Germany, Japan, the UK and the US.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
28 Nov 2023 10:33

AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
9 Nov 2023 12:54

EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Sep 2023 21:19

EARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widens

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
24 Aug 2023 14:45

Fusion Antibodies appoints interim finance chief

(Sharecast News) - Preclinical antibody developer Fusion Antibodies announced the immediate appointment of Stephen Smyth as its interim chief financial officer on Thursday.

Read more
24 Aug 2023 12:10

IN BRIEF: Fusion Antibodies appoints part-time CFO on cash struggles

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth as interim chief financial officer with immediate effect. Smyth was previously CFO at Sera Global LP, and has held senior finance positions at Cormark Securities Inc and PricewaterhouseCoopers LLP. He is currently a partner at FPM Accountants Ltd.

Read more
21 Aug 2023 13:43

Fusion Antibodies progresses AI antibody collaboration

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies updated the market on its 'AI/ML-Ab', or AIM-Lab, service on Monday.

Read more
21 Aug 2023 10:29

AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
21 Aug 2023 09:35

Fusion Antibodies inks deal with AI learning firm, hails lower costs

(Alliance News) - Fusion Antibodies PLC on Monday said it signed an agreement with an unnamed artificial intelligence & machine learning company, which it said could cut costs per sequence test significantly.

Read more
14 Aug 2023 08:41

Fusion Antibodies completes "difficult" restructuring

(Alliance News) - Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million.

Read more
1 Jun 2023 15:52

UK shareholder meetings calendar - next 7 days

Friday 2 June 
Cap-XX LtdGM re fundraising
Conduity Capital PLCGM re future direction of the company
Kibo Energy PLCEGM re renewal of director authorisations to issue shares
Mirriad Advertising PLCGM re new ordinary shares admitted to trading on AIM
Purplebricks Group PLCGM re proposed sale of business & assets to Strike Ltd
Monday 5 June 
EnQuest PLCAGM
Tuesday 6 June 
Billington Holdings PLCAGM
Mast Energy Developments PLCAGM
NB Global Monthly Income Fund LtdAGM
Tasty PLCAGM
WANdisco PLCGM re new shares authorisation and fundraise
Wednesday 7 June 
City Pub Group PLCAGM
Gem Diamonds LtdAGM
Gulf Marine Services PLCAGM
Hostmore PLCAGM
LXi REIT PLCAGM
Pennant International Group PLCAGM
Third Point Investors LtdAGM
United Oil & Gas PLCAGM
Xpediator PLCGM re takeover by DLM Bidco
Thursday 8 June 
Ashtead Technology Holdings PLCAGM
Camellia PLCAGM
Checkit PLCAGM
Churchill China PLCAGM
CRH PLCCourt Meeting and EGM re proposal to transfer the company's primary listing to NYSE
Downing Renewables & Infrastructure Trust PLCAGM
Fair Oaks Income LtdAGM
Fusion Antibodies PLCGM re result of retail offer
Genflow Biosciences PLCAGM
Glenveagh Properties PLCAGM
Kavango Resources PLCAGM
Kosmos Energy LtdAGM
Melrose Industries PLCAGM
North American Income Trust PLCAGM
Oriole Resources PLCAGM
Panther Metals PLCAGM
REA Holdings PLCAGM
Renalytix PLCGM re director's authorization to allot new shares and equity securities for cash
Vaalco Energy IncAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
19 May 2023 11:43

IN BRIEF: Fusion Antibodies shares drop after placing at 84% discount

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Raises GBP1.6 million through a placing and director subscription of 31.2 million shares at 5 pence per share, which is an 84% discount to the stock's close on Thursday of 32.06p. The placing is run by broker Allenby Capital Ltd. Fusion also launches a separate retail offer via the REX platform of up to 10.0 million shares at the same price, to raise up to an additional GBP500,000.

Read more
21 Mar 2023 10:58

Fusion Antibodies files patent application for cancer treatment

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has filed a patent application for a panel of antibodies that bind to an important target for cancer therapeutics.

Read more
6 Mar 2023 16:26

Contract suspensions see Fusion Antibodies warn on revenue

(Sharecast News) - Contract research organisation Fusion Antibodies issued a revenue warning on Monday, after a "challenging" first six months of trading as a number of valuable projects were suspended by clients due to delayed investment.

Read more
6 Mar 2023 12:16

LONDON MARKET MIDDAY: Mining stocks weigh on blue-chip index

(Alliance News) - Stock prices in London were largely lower at midday on Monday, with the FTSE 100 trading in the red, weighed down by poor performances by mining stocks.

Read more
6 Mar 2023 10:52

Fusion Antibodies drops as annual revenue seen significantly lower

(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.